The CLIA-lab test marks HistoIndex’s expansion from research to routine diagnostics, offering AI-based digital pathology for quantitative liver fibrosis assessment in patients with MASH.
Researchers are developing a large-scale olfactory dataset to train artificial intelligence, potentially unlocking smell as a powerful tool for early disease detection.
The DX-8 Series system combines CBC+DIFF, CRP, SAA, and HbA1c testing in a single platform with throughput up to 100 tests per hour.
The quality control product now includes eight opioid drugs or drug metabolites at concentrations above and below assay cutoffs.
OncoGenDx analyzes 335 DNA genes and 72 RNA genes using next-generation sequencing technology to support treatment decisions.
